Want to join the conversation?
Canadian pharmaceutical $VRX reported a wider 2Q16 loss due to decline in product sales from existing business and negative foreign currency exchange impact. Net loss widened to $302.3MM or $0.88 per share from $53MM or $0.15 per share last year. Revenues fell to $2.42Bil from $2.73Bil. Adjusted EPS decreased to $1.40 from $2.14.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!